日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD8 co-receptor modulates the specificity profile of the 1G4 TCR against NY-ESO-1

CD8 共受体调节 1G4 TCR 对 NY-ESO-1 的特异性谱

Heather F Jones ,Zita E H Aretz ,Ron S Gejman ,Tara Cicic ,David A Scheinberg

Engineered Lactococcus lactis biovaccine containing NY-ESO-1 long peptides as potent immunotherapeutics

含有NY-ESO-1长肽的工程化乳酸乳球菌生物疫苗作为强效免疫治疗剂

Chunyi Li ,Kongcheng Wang ,Jie Shao ,Junmeng Zhu ,Yaohua Ke ,Baorui Liu ,Lanqi Cen

NY-ESO-1 facilitates anoikis resistance and tumor metastasis by hijacking deubiquitinase OTUB1 to stabilize PP1α

NY-ESO-1通过劫持去泛素化酶OTUB1稳定PP1α,从而促进细胞凋亡抵抗和肿瘤转移。

Pengchao Zhang # ,Jian Cheng # ,Zhao Liu # ,Funmilayo O Adeshakin # ,Liujiang Dai ,Xiangyun Niu ,Ziyang Zhang ,Xixia Peng ,Long Li ,Maoxuan Liu ,Dehong Yan ,Xiaolu Yang ,Xiaochun Wan ,Guizhong Zhang

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade

稳定的iRGD修饰增强了NY-ESO-1 TCR-T细胞在实体瘤中的浸润,并与PD-1阻断产生协同作用。

Yirong Wu ,Lanqun Qin ,Jiayu Wang ,Ziyao Xie ,Xinyu Su ,Xiang Li ,Yueling Yang ,Rong Huang ,Mengke Zhao ,Lianjun Zhao ,Zhengyun Zou

Decoding NY-ESO-1 TCR T cells: transcriptomic insights reveal dual mechanisms of tumor targeting in a melanoma murine xenograft model

解码 NY-ESO-1 TCR T 细胞:转录组学分析揭示黑色素瘤小鼠异种移植模型中肿瘤靶向的双重机制

Alaa Alsalloum # ,Saleh Alrhmoun # ,Olga Perik-Zavosdkaia # ,Marina Fisher ,Marina Volynets ,Julia Lopatnikova ,Roman Perik-Zavodskii ,Julia Shevchenko ,Julia Philippova ,Olga Solovieva ,Evgenii Zavjalov ,Vasily Kurilin ,Hiroshi Shiku ,Alexander Silkov ,Sergey Sennikov

Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro

NY-ESO-1表位与热休克蛋白70的融合增强了其诱导的免疫反应和体外抗胶质瘤的抗肿瘤活性。

Yuqing Chen ,Lin Zheng ,Wenxi Hua ,Jie Wang ,Lihong Chen ,Aimin Huang ,Wenmin Zhang

Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma

一项评估NY-ESO-1特异性TCR T细胞治疗HLA-A∗02:01阳性晚期软组织肉瘤患者的安全性和有效性的I期临床试验

Qiuzhong Pan ,Desheng Weng ,Jiayong Liu ,Zhaosheng Han ,Yusheng Ou ,Bushu Xu ,Ruiqing Peng ,Yi Que ,Xizhi Wen ,Jing Yang ,Shi Zhong ,Lun Zeng ,Aiyuan Chen ,Haiping Gong ,Yanmei Lin ,Jiewen Chen ,Ke Ma ,Johnson Y N Lau ,Yi Li ,Zhengfu Fan ,Xing Zhang

Reprogramming of IL-12 secretion in the PDCD1 locus improves the anti-tumor activity of NY-ESO-1 TCR-T cells

PDCD1基因座IL-12分泌的重编程可增强NY-ESO-1 TCR-T细胞的抗肿瘤活性。

Segi Kim ,Cho I Park ,Sunhwa Lee ,Hyeong Ryeol Choi ,Chan Hyuk Kim

TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors

靶向 NY-ESO-1 的 TCR 工程化淋巴细胞:体外抗肿瘤细胞毒性评估

Alaa Alsalloum ,Saleh Alrhmoun ,Julia Shevchenko ,Marina Fisher ,Julia Philippova ,Roman Perik-Zavodskii ,Olga Perik-Zavodskaia ,Julia Lopatnikova ,Vasily Kurilin ,Marina Volynets ,Yasushi Akahori ,Hiroshi Shiku ,Alexander Silkov ,Sergey Sennikov

Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma

生物标志物与滑膜肉瘤患者对 NY-ESO-1 TCR T 细胞的反应相关

Alexandra Gyurdieva ,Stefan Zajic ,Ya-Fang Chang ,E Andres Houseman ,Shan Zhong ,Jaegil Kim ,Michael Nathenson ,Thomas Faitg ,Mary Woessner ,David C Turner ,Aisha N Hasan ,John Glod ,Rosandra N Kaplan ,Sandra P D'Angelo ,Dejka M Araujo ,Warren A Chow ,Mihaela Druta ,George D Demetri ,Brian A Van Tine ,Stephan A Grupp ,Gregg D Fine ,Ioanna Eleftheriadou